Prognostic significance of the tumor volume and tumor percentage for localized prostate cancer

Korean Journal of Urology

Volumn 49, Issue 12, 2008, Pages 1074-1080

  Chung, Jae Seung ^a   Han, Byoung Kyu ^b   Jeong, Seong Jin ^b   Hong, Sung Kyu ^b   Byun, Seok Soo ^b   Choe, Gheeyoung ^b   Lee, Sang Eun ^b  

^a CHA University   (South Korea)

^b Seoul National University Bundang Hospital   (South Korea)

Author keywords

Prostatectomy; Prostatic neoplasms; Recurrence

Indexed keywords

ADULT; AGED; ARTICLE; CANCER STAGING; CLINICAL ASSESSMENT; HUMAN; MAJOR CLINICAL STUDY; MALE; ONCOLOGICAL PARAMETERS; OUTCOME ASSESSMENT; PATHOLOGY; PROGNOSIS; PROSTATE CANCER; PROSTATECTOMY; TUMOR CLASSIFICATION; TUMOR LOCALIZATION; TUMOR PERCENTAGE; TUMOR RECURRENCE; TUMOR VOLUME;

EID: 58149299710     PISSN: 04944747     EISSN: None     Source Type: Journal    
DOI: 10.4111/kju.2008.49.12.1074     Document Type: Article

References (23)

1. Chun FK, Graefen M, Zacharias M, Haese A, Steuber T, Schlomm T, et al. Anatomic radical retropubic prostatectomy-long-term recurrence-free survival rates for localized prostate cancer. World J Urol 2006;24:273-80
2. Kupelian PA, Katcher J, Levin HS, Klein EA. Stage T1-2 prostate cancer: a multivariate analysis of factors affecting biochemical and clinical failures after radical prostatectomy. Int J Radiat Oncol Biol Phys 1997;37:1043-52
3. Walsh PC, Partin AW, Epstein JI. Cancer control and quality of life following anatomical radical retropubic prostatectomy: results at 10 years. J Urol 1994;152:1831-6
4. Zincke H, Bergstralh EJ, Blute ML, Myers RP, Barrett DM, Lieber MM, et al. Radical prostatectomy for clinically localized prostate cancer: long-term results of 1,143 patients from a single institution. J Clin Oncol 1994;12:2254-63
5. Bastian PJ, Gonzalgo ML, Aronson WJ, Terris MK, Kane CJ, Amling CL, et al. Clinical and pathologic outcome after radical prostatectomy for prostate cancer patients with a preoperative Gleason sum of 8 to 10. Cancer 2006;107:1265-72
6. Carver BS, Bianco FJ Jr, Scardino PT, Eastham JA. Longterm outcome following radical prostatectomy in men with clinical stage T3 prostate cancer. J Urol 2006;176:564-8
7. Ross PL, Gerigk C, Gonen M, Yossepowitch O, Cagiannos I, Sogani PC, et al. Comparisons of nomograms and urologists' predictions in prostate cancer. Semin Urol Oncol 2002;20:82-8
8. Freedland SJ, Mangold LA, Walsh PC, Partin AW. The prostatic specific antigen era is alive and well: prostatic specific antigen and biochemical progression following radical prostatectomy. J Urol 2005;174:1276-81
9. McNeal JE, Bostwick DG, Kindrachuk RA, Redwine EA, Freiha FS, Stamey TA. Patterns of progression in prostate cancer. Lancet 1986;1:60-3
10. McNeal JE, Villers AA, Redwine EA, Freiba FS, Stamey TA. Capsular penetration in prostate cancer. Significance for natural history and treatment. Am J Surg Pathol 1990;14:240-7
11. Guzzo TJ, Vira MA, Neway W, Hwang WT, Tomaszewski J, VanArsdalen K, et al. Minimal tumor volume may provide additional prognostic information in good performance patients after radical prostatectomy. Urology 2007;69:1147-51
12. Merrill MM, Lane BR, Reuther AM, Zhou M, Magi-Galluzzi C, Klein EA. Tumor volume does not predict for biochemical recurrence after radical prostatectomy in patients with surgical Gleason score 6 or less prostate cancer. Urology 2007;70:294-8
13. Stamey TA, McNeal JE, Yemoto CM, Sigal BM, Johnstone IM. Biological determinants of cancer progression in men with prostate cancer. JAMA 1999;281:1395-400
14. Epstein JI, Carmichael M, Partin AW, Walsh PC. Is tumor volume an independent predictor of progression following radical prostatectomy? A multivariate analysis of 185 clinical stage B adenocarcinomas of the prostate with 5 years of follow up. J Urol 1993;149:1478-81
15. Kikuchi E, Scardino PT, Wheeler TM, Slawin KM. Ohori M. Is tumor volume an independent prognostic factor in clinically localized prostate cancer? J Urol 2004;172:508-11
16. Salomon L, Levrel O, Anastasiadis AG, Irani J, De La Taille A, Saint F, et al. Prognostic significance of tumor volume after radical prostatectomy: a multivariate analysis of pathological prognostic factors. Eur Urol 2003;43:39-44
17. Ohori M, Wheeler TM, Kattan MW, Goto Y, Scardino PT. Prognostic significance of positive surgical margins in radical prostatectomy specimens. J Urol 1995;154:1818-24
18. D'Amico AV, Cote K, Loffredo M, Renshaw AA, Chen MH. Pretreatment predictors of time to cancer specific death after prostate specific antigen failure. J Urol 2003;169:1320-4
19. McNeal JE. Origin and development of carcinoma in the prostate. Cancer 1969;23:24-34
20. Lee KR, Cheon J. Clinical significance of calculated prostate cancer volume as the predictor of pathologic stage. Korean J Urol 2001;42:821-7
21. Freedland SJ, Isaacs WB, Platz EA, Terris MK, Aronson WJ, Amling CL, et al. Prostate size and risk of high-grade, advanced prostate cancer and biochemical progression after radical prostatectomy: a search database study. J Clin Oncol 2005;23:7546-54
22. Rampersaud EN, Sun L, Moul JW, Madden J, Freedland SJ. Percent minor involvement and risk of biochemical progression after radical prostatectomy. J Urol 2008;180:571-6
23. Noguchi M, Stamey TA, McNeal JE, Yemoto CE. Assessment of morphometric measurements of prostate carcinoma volume. Cancer 2000;89:1056-64